The combination was found to be effective in preventing the progression of advanced-stage AMD by restoring the level of rhodopsin, cone opsin and cone arrestin, and decreasing the level of carboxyethylpyrrole (CEP) adducts. This evidence concerns the gene ARR3 and age-related macular degeneration.